SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals informs about trading window closure

25 Mar 2026 Evaluate
SMS Pharmaceuticals has informed that the Trading Window for dealing in shares of the Company for all designated persons and their immediate relatives shall remain closed from 01st April, 2026 till 48 hours after the declaration of financial results for the fourth quarter and year ended 31st March, 2026. The date of Board Meeting for the consideration of financial results of the Company for the fourth quarter and year ended 31st March, 2026 shall be intimated in due course of time.

The above information is a part of company’s filings submitted to BSE.

SMS Pharmaceuticals Share Price

416.80 -10.80 (-2.53%)
20-Apr-2026 15:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.95
Dr. Reddys Lab 1233.20
Cipla 1231.45
Zydus Lifesciences 937.70
Lupin 2329.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×